Journal of Comprehensive Pediatrics

Published by: Kowsar

Brain Natriuretic Peptide: A Predictor for Severity Respiratory Distress Syndrome in Newborns

Iraj Shahramian 1 , Noor Mohammad Noori 2 , * , Elham Sharafi 3 , Abbas Ali Ramezani 4 and Mehran Hesaraki 5
Authors Information
1 Department of Pediatrics, Children and Adolescents Health Research Center, School of Medicine, Zabol Medical University, Zabol, IR Iran
2 Department of Pediatrics, Children and Adolescents Health Research Center, Zahedan Medical University, Zahedan, IR Iran
3 Department of Ophtalmology, Zahedan Medical University, Zahedan, IR Iran
4 Department of Health, Zabol Medical University, School of Health, Zabol, IR Iran
5 Department of Pediatrics, Zabol Medical University, School of Medicine, Zabol, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: November 10, 2013, 4 (4); 189-93
  • Published Online: November 1, 2013
  • Article Type: Research Article
  • Received: March 19, 2013
  • Revised: June 29, 2013
  • Accepted: August 28, 2013
  • DOI: 10.17795/compreped-11262

To Cite: Shahramian I, Noori N M, Sharafi E, Ramezani A A, Hesaraki M. Brain Natriuretic Peptide: A Predictor for Severity Respiratory Distress Syndrome in Newborns, J Compr Ped. 2013 ; 4(4):189-93. doi: 10.17795/compreped-11262.

Abstract
Copyright © 2013, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Dushianthan A, Grocott MP, Postle AD, Cusack R. Acute respiratory distress syndrome and acute lung injury. Postgrad Med J. 2011; 87(1031): 612-22[DOI][PubMed]
  • 2. Kramer MS, Demissie K, Yang H, Platt RW, Sauve R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA. 2000; 284(7): 843-9[PubMed]
  • 3. Walsh-Sukys MC, Bauer RE, Cornell DJ, Friedman HG, Stork EK, Hack M. Severe respiratory failure in neonates: mortality and morbidity rates and neurodevelopmental outcomes. J Pediatr. 1994; 125(1): 104-10[PubMed]
  • 4. Varvarigou AA, Thomas I, Rodi M, Economou I, Mantagos S, Mouzaki A. Respiratory distress syndrome (RDS) in premature infants is underscored by the magnitude of Th1 cytokine polarization. Cytokine. 2012; 58(3): 355-60[DOI][PubMed]
  • 5. Takeda K, Okamoto M, de Langhe S, Dill E, Armstrong M, Reisdorf N, et al. Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease. Anat Rec (Hoboken). 2009; 292(7): 1045-61[DOI][PubMed]
  • 6. Uno K, Merges CA, Grebe R, Lutty GA, Prow TW. Hyperoxia inhibits several critical aspects of vascular development. Dev Dyn. 2007; 236(4): 981-90[DOI][PubMed]
  • 7. Koivisto M, Marttila R, Saarela T, Pokela ML, Valkama AM, Hallman M. Wheezing illness and re-hospitalization in the first two years of life after neonatal respiratory distress syndrome. J Pediatr. 2005; 147(4): 486-92[DOI][PubMed]
  • 8. Hermansen CL, Lorah KN. Respiratory distress in the newborn. Am Fam Physician. 2007; 76(7): 987-94[PubMed]
  • 9. Mannarino S, Garofoli F, Cerbo RM, Perotti G, Mongini E, Codazzi C, et al. Cord blood, perinatal BNP values in term and preterm newborns. Arch Dis Child Fetal Neonatal Ed. 2010; 95(1)[DOI][PubMed]
  • 10. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998; 339(5): 321-8[DOI][PubMed]
  • 11. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007; 50(25): 2357-68[DOI][PubMed]
  • 12. Cantinotti M, Clerico A, Murzi M, Vittorini S, Emdin M. Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology. Clin Chim Acta. 2008; 390(1-2): 12-22[DOI][PubMed]
  • 13. Mariani G, Dik PB, Ezquer A, Aguirre A, Esteban ML, Perez C, et al. Pre-ductal and post-ductal O2 saturation in healthy term neonates after birth. J Pediatr. 2007; 150(4): 418-21[DOI][PubMed]
  • 14. Agrons GA, Courtney SE, Stocker JT, Markowitz RI. From the archives of the AFIP: Lung disease in premature neonates: radiologic-pathologic correlation. Radiographics. 2005; 25(4): 1047-73[DOI][PubMed]
  • 15. Speer CP. Neonatal respiratory distress syndrome: an inflammatory disease? Neonatology. 2011; 99(4): 316-9[DOI][PubMed]
  • 16. Mannarino S, Garofoli F, Mongini E, Cerbo RM, Codazzi AC, Tzialla C, et al. BNP concentrations and cardiovascular adaptation in preterm and fullterm newborn infants. Early Hum Dev. 2010; 86(5): 295-8[DOI][PubMed]
  • 17. Noori NM, Mohammadi M, Khazaei HA, Mahjoubifard M. Evaluation of Brain Natriuretic Peptides in Early Diagnosis of Cardiac Involvement Comparing to Echocardiographic Findings in Major Thalassemia Patients. Iranian J Cardiac Surg. 2012; 4(1): 7-12
  • 18. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988; 332(6159): 78-81[DOI][PubMed]
  • 19. Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol. 1992; 54: 11-27[DOI][PubMed]
  • 20. Nir A, Lindinger A, Rauh M, Bar-Oz B, Laer S, Schwachtgen L, et al. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol. 2009; 30(1): 3-8[DOI][PubMed]
  • 21. Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr. 2005; 147(1): 38-42[DOI][PubMed]
  • 22. Bourbon J, Boucherat O, Chailley-Heu B, Delacourt C. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res. 2005; 57(5 Pt 2): 38R-46R[DOI][PubMed]
  • 23. Eber E, Zach MS. Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). Thorax. 2001; 56(4): 317-23[PubMed]
  • 24. da Graca RL, Hassinger DC, Flynn PA, Sison CP, Nesin M, Auld PA. Longitudinal changes of brain-type natriuretic peptide in preterm neonates. Pediatrics. 2006; 117(6): 2183-9[DOI][PubMed]
  • 25. El-Khuffash A, Molloy E. The Use of N-Terminal-Pro-BNP in Preterm Infants. Int J Pediatr. 2009; 2009: 175216[DOI][PubMed]
  • 26. Joseph L, Nir A, Hammerman C, Goldberg S, Ben Shalom E, Picard E. N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants. Am J Perinatol. 2010; 27(5): 381-6[DOI][PubMed]
  • 27. Moriichi A, Cho K, Mizushima M, Furuse Y, Akimoto T, Yamada T, et al. B-type natriuretic peptide levels at birth predict cardiac dysfunction in neonates. Pediatr Int. 2012; 54(1): 89-93[DOI][PubMed]
  • 28. Tanaka T, Kanda T, Takahashi T, Saegusa S, Moriya J, Kurabayashi M. Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J Int Med Res. 2004; 32(1): 57-61[PubMed]
  • 29. Karadag R, Sen A, Yildirim N, Basmak H, Golemez H, Cakir E, et al. The relation between intraocular pressure change and plasma natriuretic peptide under simulated hypobaric conditions. Indian J Ophthalmol. 2010; 58(3): 195-8[DOI][PubMed]
  • 30. Aydemir O, Aydemir C, Sarikabadayi YU, Altug N, Erdeve O, Uras N, et al. The role of plasma N-terminal pro-B-type natriuretic peptide in predicting the severity of transient tachypnea of the newborn. Early Hum Dev. 2012; 88(5): 315-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments